Docetaxel (Taxotere) Induced Subacute Cutaneous Lupus Erythematosus: Report of 4 Cases

Journal of Rheumatology

Volumn 31, Issue 4, 2004, Pages 818-820

  Chen, Michael ^a   Crowson, A Neil ^a,b   Woofter, Melinda ^a,c   Luca, Mary Beth ^a,d   Magro, Cynthia M ^a,e  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Midwest Dermatology Centre   (United States)

^d Division of Dermatology

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Cutaneous lupus erythematosus; Docetaxel; Nucleosome

Indexed keywords

CAPECITABINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; DOCETAXEL; GEMCITABINE; IMMUNOGLOBULIN G; MUCIN; PACLITAXEL; PREDNISONE; RO ANTIBODY; TRASTUZUMAB;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER RECURRENCE; CASE REPORT; DERMATITIS; DRUG CYTOTOXICITY; DRUG INDUCED DISEASE; ERYTHEMA; FEMALE; HUMAN; IMMUNOFLUORESCENCE; KERATINOCYTE; LIVER METASTASIS; LYMPH NODE DISSECTION; NUCLEOSOME; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL MARKERS; COMPLEMENT MEMBRANE ATTACK COMPLEX; DERMATITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; MUCINS; RECOVERY OF FUNCTION; REMISSION INDUCTION; SKIN; TAXOIDS;

EID: 1842478274     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Crowson AN, Magro CM. The cutaneous pathology of lupus erythematosus. J Cutan Pathol 2001;28:1-23.
2. Magro CM, Crowson AN, Harrist TJ. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol 1996;134:855-62.
3. Goodrich AL, Kohn SR. Hydrochlorothiazide-induced lupus erythematosus: a new variant? J Am Acad Dermatol 1993;28:1001-2.
4. Darken M, McBurney EI. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene. J Am Acad Dermatol 1988;18:38-42.
5. Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003;139:45-9.
6. Crowson AN, Magro CM. Diltiazem and subacute cutaneous lupus erythematosus-like lesions [letter]. New Engl J Med 1995;333:1429.
7. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus in the setting of calcium channel blocker therapy. Hum Pathol 1997;28:67-73.
8. Ross S, Ormerod AD, Roberts C, Dwyer C, Herriot R. Subacute cutaneous lupus erythematosus associated with phenytoin. Clin Exp Dermatol 2002;27:474-6.
9. Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH. Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology Oxford 2001;40:1317-9.
10. Toll A, Campo-Pisa P, Gonzalez-Castro J, et al. Subacute cutaneous lupus erythematosus associated with cinnarizine and thielylperazine therapy. Lupus 1998;7:364-6.
11. Crowson AN, Magro CM. Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy. J Cutan Pathol 1999;26:95-9.
12. Ghate JV, Turner ML, Rudek MA, et al. Drug-induced lupus associated with COL-3. Arch Dermatol 2001;137:471-4.
13. Bonsmann G, Schiller M, Luger TA, Stander S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001;44:925-31.
14. Murphy M, Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol 1998;138:708-9.
15. Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus 2002;11:787-9.